ArticleVeterinary research communications2025
Evaluation of a competitive ELISA for detecting the anti-Brucella antibodies in serum and milk of goats and cattle.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Many serological tests are available for brucellosis diagnosis in ruminants. Some are rapid, objective and cost-effective compared to other tests, but others are highly complex, time consuming, and present subjectivity in results interpretation. Here, we optimized and validated an in-house rapid competitive ELISA (cELISA) using a monoclonal antibody against Brucella abortus oligo-polysaccharide (MAb BC68) for the serodiagnosis of caprine brucellosis and evaluated its putative utility in bovine serum and caprine milk samples. All assays were performed using samples from female animals that tested either consistently negative or consistently positive in both the buffered plate antigen (BPA) and complement fixation (CF) tests. Optimization of cELISA conditions and HRP-conjugation of BC68 allowed reducing incubation time from 4 h in 4 steps to 1.5 h in 2 steps. Using 499 goat serum samples, a cut-off value of 20.28% of inhibition (%INH) was determined by receiver operator characteristic (ROC) analysis. Then, the BC68-HRP cELISA was successfully validated in an independent goat serum sample with a good relative sensitivity (rSe = 90.28%, 95% CI = 86.31–93.19%) and a high relative specificity (rSp = 98.34%, 95% CI = 96.17–99.29%), showing a great agreement with both BPA/CF concordant results (k = 0.892, n = 593) and a commercial iELISA kit (k = 0.936, n = 217), by Cohen’s kappa analysis. On the other hand, an even better optimization of BC68-HRP cELISA parameters was achieved for bovine serum samples (n = 216), with a cut-off value of 25.50%INH and an associated rSe of 96.15% (95% CI = 90.53% − 98.49%) and rSp of 100% (95% CI = 96.68–100%). Finally, a proof-of-concept study suggested a potential utility of BC68-HRP cELISA for brucellosis diagnosis in caprine milk, with a cut-off value of 38.73%INH and an associated Se of 71.43% (95% CI = 50.04–86.19%) and Sp of 89.80% (95% CI = 78.24–95.56%) (n = 70). In conclusion, this work suggests that BC68-HRP cELISA would be useful as a time-saving and easy test for serodiagnosis of ruminant brucellosis. Furthermore, exploratory results encourage a further, larger optimization study in milk samples.
Indexed as
Identifiers
41452482What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.